IP Library › Granted Patent US 12,239,842
Granted Patent B2
US 12,239,842 · App. 17/158,755 · Granted Mar 4, 2025

Method and apparatus for inhibiting the growth of proliferating cells or viruses

Inventors: Rodolfo Nicacio (Richland, WA); Michael Colton (Richland, WA); Solomon Berecha Erpasa (Bellevue, WA)
Assignee: ACTT Medical Inc.
A61N1/40A61N1/0456A61N1/36002A61N1/3601A61N2/02H02J50/10H01F1/34H01F27/2823H01F38/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,239,842
App. No.
17/158,755
Granted
Mar 4, 2025
Kind
B2
Abstract

The present invention provides a method of inhibiting the growth of proliferating cells or viruses in living tissue, the method comprising: applying mid-level frequency AC current electromagnetic signals to the living tissue with a transducer comprising a magnetically conductive material passing through a conduction ring energized by an electrical signal to create the mid-level frequency AC current electromagnetic signals within the living tissue; wherein the mid-level frequency AC current electromagnetic signals have a frequency in the range of about 50 kHz to about 300 kHz and are produced with an AC voltage generator; and circulating fluid in the living tissue provide a secondary coil for the transmission of the mid-level frequency AC current electromagnetic signals.

Claims (22)

1. A method of inhibiting the growth of proliferating cells or viruses in living tissue of a subject, the method comprising:

applying mid-level frequency electromagnetic signals to the living tissue with a transducer comprising a magnetically conductive material passing through a conduction ring energized by an electrical signal to create the mid-level frequency electromagnetic signals within the living tissue, wherein the magnetically conductive material comprises a wire;

wherein the mid-level frequency electromagnetic signals have a mid-level frequency in a range of 50 kHz to 300 kHz;

wherein the conduction ring is energized by the transducer;

wherein circulating fluid in the living tissue provides a secondary coil for the transmission of the mid-level frequency electromagnetic signals thereby allowing for efficient transfer of energy internally within the living tissue;

wherein the inhibition of the growth of the proliferating cells or viruses is not caused by heat; and

wherein the transducer further comprises at least one wire connected to a ground; and the at least one wire passes through the conduction ring and is connected to the living tissue in the subject.

2. The method of claim 1 , wherein the at least one wire is connected to the conduction ring or is looped around the conduction ring at least once.

3. The method of claim 1 , wherein the at least one wire is connected to the living tissue transcutaneously with Transcutaneous Electrical Nerve Stimulation (TENS) pads or TENS-like pads.

4. The method of claim 1 , wherein the at least one wire is connected to an intravenous fluid therapy unit.

5. The method of claim 1 , wherein the at least one wire is connected to a grounding device that is wrapped around the living tissue.

6. The method of claim 1 , wherein the proliferating cells are cancer cells in a tumor and the at least one wire is connected to the living tissue at a site within 25 cm from the tumor.

7. An apparatus for inhibiting the growth of proliferating cells or viruses in living tissue of a subject, the apparatus comprising:

a transducer comprising a magnetically conductive material passing through a conduction ring energized by an electromagnetic signal to create mid-level frequency electromagnetic signals within a living tissue, wherein the transducer is configured to generate mid-level frequency AC current electromagnetic signals in the range of 50 kHz to 300 kHz; and

at least one wire forming a secondary coil connected to a ground, and passing through the conduction ring of the transducer,

wherein the at least one wire is designed to be transcutaneously connected to the living tissue with Transcutaneous Electrical Nerve Stimulation (TENS) pads or TENS-like pads, and

wherein the conduction ring is energized by the transducer.

8. The apparatus of claim 7 , wherein the conduction ring is energized by an electromagnetic signal generated and amplified by an amplifier and transmitted wirelessly from a transmitter through an antenna, wherein the receiver is conductively coupled to the conduction ring.

9. The apparatus of claim 7 , further comprising a frequency modulator that adjusts the mid-level frequency electromagnetic signals.

10. The apparatus of claim 7 , wherein the conduction ring of the transducer is designed to extend around the living tissue or some portion thereof.

11. The apparatus of claim 7 , wherein the magnetically conductive material is flexible.

12. The apparatus of claim 7 , wherein the at least one wire is connected to the conduction ring and/or is looped around the conduction ring at least once.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2021
From: NICACIO, RODOLFO; COLTON, MICHAEL; ERPASA, SOLOMON BERECHA
To: ALTERNATING CURRENT TREATMENT THERAPY MEDICAL INC.
Reel/Frame 055192/0552 →
Continuity (4)
Provisional Application 63045830 · Jun 29, 2020
Provisional Application 62987344 · Mar 9, 2020
Provisional Application 62966513 · Jan 27, 2020
Related Publication 20210228895A1 · Jul 29, 2021
References Cited (13)
US 5928940A · Sampath et al. · 1999 [cited by applicant]
US 20040193003A1 · Mechlenburg et al. · 2004 [cited by applicant]
US 20090027050A1 · Garwood et al. · 2009 [cited by applicant]
US 20110077451A1 · Marchitto et al. · 2011 [cited by applicant]
US 20110137229A1 · Palti · 2011 [cited by examiner]
US 20120016174A1 · De Taboada · 2012 [cited by examiner]
US 20120267986A1 · Galluzzo et al. · 2012 [cited by applicant]
US 20190001151A1 · Abdolahad · 2019 [cited by examiner]
US 20190117969A1 · Schmidt · 2019 [cited by examiner]
US 20190126041A1 · Kerselaers · 2019 [cited by examiner]
US 20190255344A1 · Carter · 2019 [cited by examiner]
US 20200230408A1 · Errico · 2020 [cited by examiner]
EP 0894473A2 · 1999 [cited by applicant]
Cited By (1)
US 12,629,532